Hormonal Contraceptives Global Market 2024 To Reach $15.57 Billion By 2028 At Rate Of 2.2%

The Business Research Company's Hormonal Contraceptives Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LANDON, GREATER LANDON, UK, July 22, 2024 /EINPresswire.com/ -- The hormonal contraceptives market has experienced robust growth in recent years, expanding from $13.96 billion in 2023 to $14.28 billion in 2024 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to government initiatives, increase in use of contraceptives, increase in pharmaceutical r&d expenditure, increased healthcare expenditure and growth in the number of healthcare facilities.

Strong Future Growth Anticipated
The hormonal contraceptives market is projected to continue its strong growth, reaching $15.57 billion in 2028 at a compound annual growth rate (CAGR) of 2.2%. The growth in the forecast period can be attributed to the increasing awareness on family planning, increasing research and development spending, rise in healthcare expenditure, increasing collaborations between agencies.

Explore Comprehensive Insights Into The Global Hormonal Contraceptives Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=2440&type=smp

Growth Driver Of The Hormonal Contraceptives Market
The rising rate of unplanned pregnancies is expected to propel the growth of the hormonal contraceptive market. Unplanned pregnancies are defined as pregnancies that are either unwanted or unplanned, such as those that happen when no children or additional children are desired. Hormonal contraceptives provide a reliable and convenient way for individuals and couples to prevent unplanned pregnancies, allowing them to have greater control over family planning and reproductive health.

Make Your Report Purchase Here And Explore The Whole Industry's Data As Well:
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Major Players And Market Trends
Key players in the hormonal contraceptives market include Bayer AG, Merck & Co. Inc., Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited.
Major companies operating in hormonal contraceptives are developing plant-based pills such as Nextellis to enhance product offerings and gain a competitive advantage. Nextellis is a contraceptive pill containing a unique combination of 3 mg drospirenone (DRSP) and 14.2 mg estetrol (E4) tablets, offering a novel mechanism of action for pregnancy prevention.

Segments:
1) By Product: Pills, Injectable Birth Control, Vaginal Rings, Others
2) By End User: Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers
3) By Hormones: Progestin-Only, Combined Hormones
4) By Distribution Channel: Drug Stores, Gynecology/ Fertility Clinics, E-Commerce, Other Distribution Channels

Geographical Insights: North America Leading The Market
North America was the largest region in the hormonal contraceptives market share in 2023. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Hormonal Contraceptives Market Definition
Hormonal contraceptives refer to a method of birth control that stops pregnancy using hormones. There are numerous types. Some can be undone, while others are irreversible. Some varieties can also aid in the prevention of STDs.

Hormonal Contraceptives Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Hormonal Contraceptives Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on hormonal contraceptives market size, hormonal contraceptives market drivers and trends, hormonal contraceptives market major players, hormonal contraceptives competitors' revenues, hormonal contraceptives market positioning, and hormonal contraceptives market growth across geographies. The hormonal contraceptives market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Microbiology Diagnostic Devices And Equipment Global Market Opportunities And Strategies To 2031
https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-market

High Potency APIs Global Market Opportunities And Strategies To 2031
https://www.thebusinessresearchcompany.com/report/high-potency-apis-market

Gynecology Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gynecology-drugs-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn